Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Head and Neck
08:09

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRAS, Recurrent/Metastatic HNSCC"

FEATURING Alan Ho
  • 115 views
  • November 24, 2023
18:07

Nebraska Oncology Society

NOS ASCO® 2023 Review: Nasopharynx Cancer

FEATURING Eric Sherman
  • 1,785 views
  • July 3, 2023
  • 11
22:27

Nebraska Oncology Society

NOS ASCO® 2023 Review: Head & Neck Cancer De-Escalation

FEATURING Eric Sherman
  • 237 views
  • July 3, 2023
47:18

Nebraska Oncology Society

ASCO 2022 Review of Head & Neck Cancer Updates

FEATURING Eric Sherman
  • 538 views
  • June 28, 2022
  • 4
09:41

Nebraska Oncology Society

ASCO 2020 Review of Transoral Robotic Surgery for OPC : Is 2-yr PFS Favorable Without Post-Operative Therapy for Low-risk Disease Patients?

FEATURING Eric Sherman
  • 13 views
  • January 5, 2021
09:24

Nebraska Oncology Society

2020 ASCO LA-HNSCC Trials Review: What Is the Efficacy of Weekly CDDP vs. 3-Weekly CDDP?

FEATURING Eric Sherman
  • 13 views
  • January 5, 2021
11:38

Nebraska Oncology Society

ASCO 2020 Update on DO-IMRT & HNC Metastatic: Does Change in IMRT Lead to Improvement in Swallowing Function? What Are the KEYNOTE-048 Final Results Not Telling Us?

FEATURING Eric Sherman
  • 20 views
  • January 5, 2021
04:56

Nebraska Oncology Society

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy and Tolerance of Carboplatin-Cetuximab? Is Single-Agent Chemotherapy Sufficient?

FEATURING Eric Sherman
  • 15 views
  • January 5, 2021
08:09

Nebraska Oncology Society

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy of New RET Inhibitors? Should We Use Them 1L or 2L?

FEATURING Eric Sherman
  • 25 views
  • January 5, 2021